Mark V. Roeder

Partner at Latham & Watkins LLP

Mark V. Roeder

Mark V. Roeder

Partner at Latham & Watkins LLP

Overview
RelSci Relationships

2253

Number of Awards

1

Contact Data
Trying to get in touch with Mark V. Roeder? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Mark V. Roeder likely has professional access to. A relationship does not necessarily indicate a personal connection.

Partner at Latham & Watkins LLP

Relationship likelihood: Strong

Partner at Latham & Watkins LLP

Relationship likelihood: Strong

Partner at Latham & Watkins LLP

Relationship likelihood: Strong

Office Managing Partner, San Francisco at Latham & Watkins LLP

Relationship likelihood: Strong

Partner at Latham & Watkins LLP

Relationship likelihood: Strong

Managing Partner at Latham & Watkins LLP

Relationship likelihood: Strong

Chair, Industrials & Manufacturing Practice Group at Latham & Watkins LLP

Relationship likelihood: Strong

Partner at Latham & Watkins LLP

Relationship likelihood: Strong

Partner at Latham & Watkins LLP

Relationship likelihood: Strong

Partner at Latham & Watkins LLP

Relationship likelihood: Strong

Paths to Mark V. Roeder
Potential Connections via
Relationship Science
You
Mark V. Roeder
Partner at Latham & Watkins LLP
Education
JD
Class of 1995

The University of Michigan, founded in 1817, celebrates a long and distinguished history. It was in 1787 that the Northwest Territorial Ordinance provided public land for this and other Midwestern universities and established a tradition of respect for excellence in higher education. Three Native American nations—the Ojibwa (Chippewa), Odawa (Ottawa), and Bodewadini (Potawatomi)—subsequently granted certain lands for use of the University of Michigan and by the end of the 19th century, Michigan was the largest and most generously supported public university in America and already a leader in graduate education. The University of Michigan Law School, one of the oldest law schools in the nation, was founded in 1859. But unlike other highly selective law schools established in that era, admission was never restricted to the privileged. When Gabriel Hargo graduated from the Law School in 1870, Michigan—then the largest law school in the country—became the second American university to confer a law degree on an African American. That same year, Michigan was the first major law school to admit a woman, and in 1871, graduate Sarah Killgore became the first woman with a law degree in the nation to be admitted to the bar; by 1890, Michigan had graduated more women than any other law school. That commitment to access and diversity joined an equally powerful commitment to excellence, which continues to this day.

BA
Class of 1992

TO PROVIDE AN EXCEPTIONAL UNDERGRADUATE LIBERAL ARTS EDUCATION.

Career History
Partner
Current

Latham & Watkins LLP is a full-service law firm. The firm offers services in the areas of finance, litigation, tax, banking, life sciences, private equity, real estate, government relations, employment law, and outsourcing. The firm practices in a spectrum of transactional, litigation, corporate, and regulatory areas. Latham & Watkins was established in 1934 and is based in New York, New York.

Secretary
Prior

Achaogen, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections. It offers Plazomicin to treat bacterial illness, such as complicated urinary tract infection, blood stream infections, and other infections due to MDR Enterobacteriaceae. The company was founded by Nathaniel E. David in June 2002 and is headquartered in South San Francisco, CA.

Secretary
Prior

Alios BioPharma, Inc. operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases. It also develops proprietary chemical libraries of novel nucleosides, nucleoside analogs and non-nucleosides as potential therapeutics for viral infections including RSV, influenza, rhinovirus and emerging viral diseases. The firm offers VX-135, a uridine nucleotide analog for the treatment of chronic hepatitis C. The company was founded by Leonid N. Beigelman, Lawrence M. Blatt and John R. Donovan in 2008 and is headquartered in San Francisco, CA.

Transactions
Details Hidden

IDEAYA Biosciences, Inc. issued USD Common Stock

Details Hidden

Ascendis Pharma A/S issued USD American Depositary Shares

Details Hidden

NVIDIA Corp. purchases Mellanox Technologies Ltd.

Awards & Honors
Admitted to the California Bar
Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Mark V. Roeder. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Mark V. Roeder's profile does not indicate a business or promotional relationship of any kind between RelSci and Mark V. Roeder.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/mark-v-roeder-3632186
  • https://relationshipscience.com/person/mark-v-roeder-3632186